AN1
Click for more information
11.1% 0.8¢ anagenics limited

Research/Cancer: Midkine Promotes Tumour Cell Resistance to Cisplatin

  1. mightypirate
    551 Posts.
    lightbulb Created with Sketch. 173
    clock Created with Sketch.
    13/12/17
    10:25
    Post #: 29590304
    Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells

    Source: Nature (https://www.nature.com/articles/s41598-017-13431-y)

    Published online: 24 November 2017

    CDY Price at posting: 38.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
-0.001(11.1%) 		Mkt cap ! $3.691M
Open High Low Value Volume
0.8¢ 0.9¢ 0.8¢ $8.671K 1.051M

Buyers (Bids)

No. Vol. Price($)
2 1735002 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.